SBRT more cost-effective, with greater improvement in quality of life than surgery. »
08/05/25

No significant differences in efficacy observed by PIK3CA mutational status. »
08/06/25

Addition of ipatasertib to capecitabine or eribulin shows potential efficacy signal. »
08/06/25

Women with CHEK2 mutation face increased risk of DCIS. »
08/06/25

Amplicon-based assays faster and required less input of DNA for analysis. »
08/06/25

Neoadjuvant chemo-radiotherapy tolerable in patients aged ≥ 70 years. »
08/07/25

E5 transcript associated with worse progression-free survival. »
08/07/25

Diabetes and breast cancer strongly associated in Pakistani adults. »
08/07/25

Overexpression of miR-451a significantly increased apoptosis and CRT surface exposureular context. »
08/07/25

Post-diagnosis weight gain associated with increased risk of all-cause mortality. »
08/08/25